Testosterone deficiency syndrome: Diagnosis and treatment

Actas Urol Esp (Engl Ed). 2020 Jun;44(5):294-300. doi: 10.1016/j.acuro.2019.10.009. Epub 2020 May 15.
[Article in English, Spanish]

Abstract

The testosterone deficiency syndrome (TDS) is a very common clinical and biochemical condition that affects approximately 2-5% men over the age of 40. From a clinical point of view, it is usually associated with decreased sexual desire and activity, erectile dysfunction, low energy and mood swings, along with T<8-12 nmol/l levels. Questionnaires are not useful in screening but may be useful for diagnosis and follow-up. Its diagnosis requires the presentation of multiple hypogonadism symptoms together with two morning T tests below the acceptable limits. LH and SHBG levels can be useful to determine the cause and the free T level, respectively. Contraindications for treatment are active prostate cancer, stage IV heart failure, breast cancer, desired fertility and hematocrit values over 54%. Treatment is based on the cause of TDS, if any, along with testosterone supplementation. The objective is to achieve normal testosterone levels. Follow-up includes clinical history, analysis (PSA, T+SHBG, hematocrit, glucose and lipid profile) and rectal examination, 3, 6 and 12 months after beginning treatment.

Keywords: Deficit de testosterona; Diagnosis; Diagnóstico; Hipogonadismo; Hypogonadism; Testosterone deficiency.

Publication types

  • Review

MeSH terms

  • Humans
  • Male
  • Syndrome
  • Testicular Diseases / diagnosis
  • Testicular Diseases / drug therapy
  • Testosterone / deficiency*

Substances

  • Testosterone